Clinical trial
Treatment and Natural History Study of Lymphomatoid Granulomatosis
NCT00001379 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001379 |
|---|---|
| Title | Treatment and Natural History Study of Lymphomatoid Granulomatosis |
| Official title | Treatment and Natural History Study of Lymphomatoid Granulomatosis |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma, Lymphoproliferative Disorder |
| Intervention type | Biological, Diagnostic Test, Drug, Procedure |
| Interventions | Interferon, Rituxan and EPOCH, Tumor biopsy, Bone marrow biopsy, Bone marrow aspirate, Lumber puncture, CT, Brain MRI, Echocardiogram, FDG-PET |
| Enrollment | 94 |
| Start date | May 5, 1995 |
| Primary completion | Jan 17, 2025 |
| Completion | Jan 17, 2025 |
| First posted | Nov 4, 1999 |
| Last update posted | Jun 19, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: